Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BSPG-Pharm
Obolensk, Moscow Oblast, Russia
- Ownership
- Private
- Development stage
- Other
01
Overview
BSPG-Pharm is a Russian pharmaceutical company focused on the development, manufacturing, and distribution of high-quality generic and innovative medicinal products. The company specializes in the production of active pharmaceutical ingredients (APIs) and finished dosage forms, particularly in the field of neurology and cognitive health. Their flagship product is often associated with Citicoline-based formulations used to treat stroke recovery and cognitive decline. BSPG-Pharm operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to ensure the safety and efficacy of its portfolio.
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on BSPG-Pharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BSPG-Pharm.